Wai Chun Bio-Technology Limited (0660.HK)
HKD 0.07
(0.0%)
HKD 0.07
(0.0%)
| Breakdown | 2023 | 2022 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 45.41 Million | 390 Thousand | -413 Thousand | 14.27 Million | -6.88 Million | 8.92 Million |
| Net Income | -15.43 Million | -14.36 Million | 1.61 Million | 9.06 Million | -53 Million | -20.63 Million |
| Depreciation & Amortization | 14.06 Million | 10.79 Million | 6.37 Million | 5.33 Million | 4.34 Million | 4.54 Million |
| Deferred income taxes | - | - | - | 2.28 Million | -4.91 Million | - |
| Stock-based compensation | - | - | - | - | 39.86 Million | - |
| Change in working capital | 26.21 Million | -37.29 Million | -20.39 Million | -7.38 Million | 2.38 Million | 16.25 Million |
| Other non-cash items | -1.5 Million | 105.41 Million | 11.99 Million | 7.26 Million | 4.44 Million | 8.76 Million |
| Investing Cash Flow | -28.17 Million | -16.68 Million | -12.52 Million | -12.76 Million | -2.5 Million | -10.15 Million |
| Investments in PPE | -28.17 Million | -16.78 Million | -12.54 Million | -12.95 Million | -6.56 Million | -8.27 Million |
| Acquisitions | - | 101 Thousand | - | -22 Thousand | 372 Thousand | - |
| Investment purchases | - | - | - | - | - | -3.42 Million |
| Sales/Maturities of investments | - | - | - | - | 3.52 Million | 1.41 Million |
| Other Investing Activities | 38 Thousand | 90.66 Thousand | 26 Thousand | 206 Thousand | 542 Thousand | 129 Thousand |
| Financing Cash Flow | -17.89 Million | 17.07 Million | 11.53 Million | -868 Thousand | 8.49 Million | -208 Thousand |
| Debt repayment | -17.89 Million | -17.07 Million | -53.92 Million | -59.77 Million | -56.58 Million | -55.01 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -21.45 Million | 8.43 Million | 65.45 Million | 58.91 Million | 65.08 Million | 54.8 Million |
| Accounts receivables | 7.87 Million | -35.72 Million | 16.91 Million | -7.38 Million | -403 Thousand | 2.03 Million |
| Accounts payables | 19.55 Million | 1.2 Million | -31.63 Million | 13.91 Million | 4.32 Million | 74 Thousand |
| Inventory | 22.77 Million | -8.05 Million | -16.93 Million | -11.2 Million | 635 Thousand | 14.83 Million |
| Other working capital | -23.98 Million | 5.28 Million | 11.26 Million | -2.71 Million | 1.74 Million | 1.42 Million |
| Cash at beginning of period | 7.52 Million | 5.44 Million | 5.4 Million | 4.53 Million | 5.82 Million | 6.46 Million |
| Cash at end of period | 6.31 Million | 7.52 Million | 5.44 Million | 5.4 Million | 4.53 Million | 5.82 Million |
| Capital Expenditure | -28.17 Million | -16.78 Million | -12.54 Million | -12.95 Million | -6.56 Million | -8.27 Million |
| Effect of forex changes on cash | -544 Thousand | 864.66 Thousand | 1.43 Million | 237 Thousand | -395 Thousand | 790 Thousand |
| Net cash flow / Change in cash | -1.2 Million | 2.07 Million | 37 Thousand | 872 Thousand | -1.28 Million | -642 Thousand |
| Free Cash Flow | 17.23 Million | -16.39 Million | -12.96 Million | 1.31 Million | -13.45 Million | 654 Thousand |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2022 FY | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.73 Million | -3.36 Million | -7.6 Million | -15.43 Million | -3.8 Million | -7.83 Million |
| Depreciation & Amortization | 5.65 Million | 2.82 Million | 8.79 Million | 14.06 Million | 4.39 Million | 5.26 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 8.62 Million | 26.21 Million | 8.62 Million | - |
| Other non-cash items | 37.05 Million | 12.87 Million | 49.94 Million | -1.5 Million | 9.31 Million | 24.96 Million |
| Investing Cash Flow | -24.24 Million | -12.12 Million | -26.01 Million | -28.17 Million | -12.99 Million | -2.15 Million |
| Investments in PPE | -24.24 Million | -12.12 Million | -26.01 Million | -28.17 Million | -13 Million | -2.15 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1500.00 | 1500.00 | 18 Thousand | 38 Thousand | 18 Thousand | 1000.00 |
| Financing Cash Flow | -1.41 Million | -706.5 Thousand | -18.57 Million | -17.89 Million | -11.06 Million | 677 Thousand |
| Debt repayment | - | - | - | -17.89 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -706.5 Thousand | -706.5 Thousand | -11.06 Million | -21.45 Million | -11.06 Million | 338.5 Thousand |
| Accounts receivables | - | - | 3.93 Million | 7.87 Million | 3.93 Million | - |
| Accounts payables | - | - | - | 19.55 Million | - | - |
| Inventory | - | - | 11.38 Million | 22.77 Million | 11.38 Million | - |
| Other working capital | - | - | -6.69 Million | -23.98 Million | -6.69 Million | - |
| Cash at beginning of period | 6.31 Million | - | 17.74 Million | 7.52 Million | 17.74 Million | 7.52 Million |
| Cash at end of period | 5.43 Million | -438.5 Thousand | 6.31 Million | 6.31 Million | -5.71 Million | 17.74 Million |
| Capital Expenditure | -24.24 Million | -12.12 Million | -26.01 Million | -28.17 Million | -13 Million | -2.15 Million |
| Effect of forex changes on cash | 56.5 Thousand | 56.5 Thousand | -192.5 Thousand | -544 Thousand | -192.5 Thousand | -79.5 Thousand |
| Net cash flow / Change in cash | -877 Thousand | -438.5 Thousand | -11.43 Million | -1.2 Million | -23.46 Million | 10.22 Million |
| Free Cash Flow | 423 Thousand | 210 Thousand | 7.52 Million | 17.23 Million | 5.52 Million | 9.7 Million |
GDC
PHIG
TTB
SICO
D2O
LTRY